Product image of Moxifloxacin Accord Healthcare (Moxifloxacin Hydrochloride) supplied by GNH India

Moxifloxacin Accord Healthcare

Active Ingredient:
Moxifloxacin Hydrochloride
Origin:
EU

Moxifloxacin Accord Healthcare (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacin Accord Healthcare, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and skin and skin‑structure infections in adults.

GNH India supplies Moxifloxacin Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Moxifloxacin is a broad‑spectrum antibacterial that targets common respiratory and skin infections.
  • Community‑acquired pneumonia: eradicates the causative bacteria to improve lung function and reduce fever.
  • Acute bacterial sinusitis: clears sinus infection, relieving congestion and facial pain.
  • Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load, helping restore normal breathing.
  • Skin and skin‑structure infections: eliminates pathogenic bacteria, promoting wound healing and preventing spread.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these enzymes, it prevents the supercoiling and separation of DNA strands, leading to bacterial cell death and a bactericidal effect against susceptible organisms.

Side Effects

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea or vomiting
  • Diarrhea or abdominal discomfort
  • Headache or dizziness
  • Rash or mild skin itching
  • Photosensitivity reactions
  • Transient elevation of liver enzymes

Serious or Rare Side Effects

  • Tendon rupture or tendinitis, especially in the Achilles tendon
  • QT interval prolongation leading to cardiac arrhythmias
  • Severe allergic reactions such as Stevens‑Johnson syndrome
  • Clostridioides difficile‑associated colitis
  • Hepatic failure or significant liver injury
  • Peripheral neuropathy or central nervous system effects

Precautions & Warnings

  • Before prescribing Moxifloxacin, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.
  • Assess renal and hepatic function: adjust therapy if impairment is present.
  • Avoid use in patients with known hypersensitivity to fluoroquinolones.
  • Monitor QT interval: caution in patients with cardiac conduction disorders.
  • Use with caution in the elderly: higher risk of tendon injury.
  • Avoid concomitant use with other fluoroquinolones or agents that prolong QT.
  • Store at ambient temperature: keep in the original container, protect from moisture.

Avoid Interactions

Moxifloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Antacids or supplements containing magnesium or aluminum: reduce absorption.
  • Warfarin: may increase anticoagulant effect and bleeding risk.
  • Other QT‑prolonging drugs (e.g., macrolides, antiarrhythmics): heighten arrhythmia risk.

Moderate Interactions (Monitor Closely)

  • CYP1A2 inhibitors such as fluvoxamine: increase plasma levels.
  • CYP3A4 inducers like rifampicin: decrease effectiveness.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may raise risk of central nervous system side effects.

Frequently Asked Questions

Moxifloxacin Accord Healthcare is indicated for the treatment of community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and skin and skin‑structure infections caused by susceptible bacteria.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition prevents bacterial cells from multiplying, leading to a bactericidal effect.

The dosage and duration are determined by the prescribing clinician based on the infection type, severity, patient age, renal and hepatic function, and local guidelines. Patients should follow the prescriber’s instructions exactly.

Safety data for Moxifloxacin in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxifloxacin offers a broader spectrum against Gram‑positive organisms and better activity in respiratory infections compared with older fluoroquinolones such as ciprofloxacin. Its dosing convenience and tissue penetration also differentiate it, though safety considerations remain similar across the class.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The medication is taken orally, usually as a tablet, with or without food as directed by the prescriber. Patients should swallow the tablet whole with a full glass of water and avoid crushing or chewing unless specifically instructed.

Serious adverse events include tendon rupture, QT‑interval prolongation leading to cardiac arrhythmias, severe hypersensitivity reactions such as Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, and significant liver injury. Patients should seek immediate medical attention if they experience any of these symptoms.

Patients with a known hypersensitivity to moxifloxacin or any fluoroquinolone, those with a history of tendon disorders related to fluoroquinolone use, and individuals with significant QT‑prolongation risk should avoid this medication. Contraindications should be confirmed by the prescribing clinician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.